Annovis Bio Priced 1M Share Public Offering @$50/Share
Annovis Bio (NYSE: ANVS) today announced the pricing of its underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $50.00 per share, for gross proceeds of $50,000,000, before deducting underwriting discounts, commissions and offering expenses.
Mid-Afternoon Market Update: Dow Rises 150 Points; VF Corp Shares Fall On Downbeat Earnings
Toward the end of trading Friday, the Dow traded up 0.44% to 34,234 while the NASDAQ fell 0.26% to 13,500.91. The S&P also rose, gaining 0.07% to 4,161.93.
64 Biggest Movers From Yesterday
Gainers
InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday.
Annovis Bio Receives US Patent For Method Of Treating Frontotemporal Dementia And Chronic Traumatic Encephalopathy
Annovis Bio Inc. (NYSE:ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced the U.S. Patent and